Theravance Biopharma CEO Rick Winningham's 2019 pay jumps 135% to $5.9M
Theravance Biopharma reports 2019 executive compensation
By ExecPay News
Published: March 24, 2020
Theravance Biopharma reported fiscal year 2019 executive compensation information on March 24, 2020.
In 2019, six executives at Theravance Biopharma received on average a compensation package of $2.8M, a 71% increase compared to previous year.
Average pay of disclosed executives at Theravance Biopharma
Rick E Winningham, Chief Executive Officer, received $5.9M in total, which increased by 135% compared to 2018. 75% of Winningham's compensation, or $4.5M, was in stock awards. Winningham also received $474K in non-equity incentive plan, $984K in salary, as well as $5.5K in other compensation.
For fiscal year 2019, the median employee pay was $219,765 at Theravance Biopharma. Therefore, the ratio of Rick E Winningham's pay to the median employee pay was 27 to one.
Andrew A. Hindman, Chief Financial Officer, received a compensation package of $3.8M. 59% of the compensation package, or $2.2M, was in option awards.
Bradford J. Shafer, General Counsel, earned $2.5M in 2019, a 120% increase compared to previous year.
Brett Haumann, Chief Medical Officer, received $2.5M in 2019, which increases by 62% compared to 2018.
Frank Pasqualone, Senior Vice President and Chief Commercial Operations Officer, earned $2.5M in 2019, a 123% increase compared to previous year.
Renee D. Gala, Chief Financial Officer, received $9.7K in 2019, which decreases by 99% compared to 2018.
Related executives
Rick Winningham
Theravance Biopharma
Chief Executive Officer
Andrew Hindman
Theravance Biopharma
Chief Financial Officer
Brett Haumann
Theravance Biopharma
Chief Medical Officer
Frank Pasqualone
Theravance Biopharma
Senior Vice President and Chief Commercial Operations Officer
Bradford Shafer
Theravance Biopharma
General Counsel
Renee Gala
Theravance Biopharma
Chief Financial Officer
You may also like
Source: SEC filing on March 24, 2020.